ONCOGON Trademark

Trademark Overview


On Thursday, March 30, 2000, a trademark application was filed for ONCOGON with the United States Patent and Trademark Office. The USPTO has given the ONCOGON trademark a serial number of 78001785. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Thursday, September 11, 2003. This trademark is owned by Immugen Pharmaceuticals, Inc.. The ONCOGON trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER AND NEOPLASTIC DISEASES, NAMELY, BREAST, COLON, LUNG, PROSTATE, OVARIAN, CENTRAL NERVOUS SYSTEM AND BLOOD DYSCRASIAS; PHARMACEUTICAL KITS FOR THE TREATMENT OF CANCER, AND BREAST, COLON, LUNG, PROSTATE, OVARIAN, CENTRAL NERVOUS SYSTEM AND BLOOD DYSCRASIAS, CONSISTING OF A COMBINATION OF SOME OR ALL OF THE FOLLOWING GOODS, NAMELY, UNIT DOSAGES OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND CENTRAL NERVOUS SYSTEM AND BLOOD DYSCRASIAS, AN ADMINISTRATIVE DEVICE IN THE NATURE OF SYRINGES, NEEDLES, INHALATORS, PILLS, SUPPOSITORIES AND TRANSDERMAL PATCHES, AND CARRYING CASE AND INSTRUCTION BOOKLET, ALL SOLD AS A UNIT
oncogon

General Information


Serial Number78001785
Word MarkONCOGON
Filing DateThursday, March 30, 2000
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateThursday, September 11, 2003
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 18, 2002

Trademark Statements


Goods and ServicesPHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CANCER AND NEOPLASTIC DISEASES, NAMELY, BREAST, COLON, LUNG, PROSTATE, OVARIAN, CENTRAL NERVOUS SYSTEM AND BLOOD DYSCRASIAS; PHARMACEUTICAL KITS FOR THE TREATMENT OF CANCER, AND BREAST, COLON, LUNG, PROSTATE, OVARIAN, CENTRAL NERVOUS SYSTEM AND BLOOD DYSCRASIAS, CONSISTING OF A COMBINATION OF SOME OR ALL OF THE FOLLOWING GOODS, NAMELY, UNIT DOSAGES OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCER AND CENTRAL NERVOUS SYSTEM AND BLOOD DYSCRASIAS, AN ADMINISTRATIVE DEVICE IN THE NATURE OF SYRINGES, NEEDLES, INHALATORS, PILLS, SUPPOSITORIES AND TRANSDERMAL PATCHES, AND CARRYING CASE AND INSTRUCTION BOOKLET, ALL SOLD AS A UNIT

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 12, 2000
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImmugen Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth Miami, FL 33143

Party NameImmugen Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth Miami, FL 33143

Trademark Events


Event DateEvent Description
Monday, November 17, 2003ABANDONMENT - NO USE STATEMENT FILED
Wednesday, September 3, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 21, 2003EXTENSION 1 GRANTED
Monday, March 10, 2003EXTENSION 1 FILED
Friday, June 13, 2003PETITION TO REVIVE-GRANTED
Monday, April 14, 2003PETITION TO REVIVE-RECEIVED
Friday, May 30, 2003ABANDONMENT - NO USE STATEMENT FILED
Monday, April 14, 2003PAPER RECEIVED
Thursday, April 10, 2003TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 10, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2002PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2002NOTICE OF PUBLICATION
Tuesday, February 26, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 30, 2002ASSIGNED TO EXAMINER
Tuesday, December 4, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 5, 2001FINAL REFUSAL MAILED
Tuesday, February 13, 2001CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 22, 2000NON-FINAL ACTION MAILED